Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Down 8.2% in October

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 36,800 shares, a drop of 8.2% from the October 15th total of 40,100 shares. Based on an average daily trading volume, of 11,400 shares, the short-interest ratio is presently 3.2 days.

Conduit Pharmaceuticals Stock Performance

Shares of NASDAQ CDTTW opened at $0.01 on Tuesday. Conduit Pharmaceuticals has a 52-week low of $0.01 and a 52-week high of $0.16. The firm’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.03.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.